Lung TransplantationHeart-Lung TransplantationBronchiolitis ObliteransLungGraft RejectionLung DiseasesPrimary Graft DysfunctionCollagen Type VTransplantationKidney TransplantationImmunosuppressive AgentsPostoperative ComplicationsTransplantsRespiratory AspirationGraft SurvivalTransplantation, HomologousTissue DonorsHeart TransplantationCytomegalovirus InfectionsBronchoalveolar Lavage FluidLung NeoplasmsBronchoalveolar LavageImmunocompromised HostRetrospective StudiesTreatment OutcomeBronchoscopyTissue and Organ ProcurementCyclosporineTime FactorsLung InjuryImmunosuppressionWaiting ListsCytomegalovirusCystic FibrosisGanciclovirPulmonary FibrosisCarcinoma, Non-Small-Cell LungLung Diseases, InterstitialTacrolimusBurkholderia gladioliMycosesOpportunistic InfectionsInvasive Pulmonary AspergillosisTransplantation ImmunologyRisk FactorsFollow-Up StudiesOrgan TransplantationProspective StudiesLung Diseases, FungalAcute Lung InjuryForced Expiratory VolumeFatal OutcomeBronchiAntifungal AgentsBiopsyRespiratory Function TestsBonding, Human-PetAspergillosisBone Marrow TransplantationSurvival RateBronchial DiseasesAntiviral AgentsPostoperative PeriodIdiopathic Pulmonary FibrosisSurvival AnalysisCohort StudiesTriazolesGastroesophageal RefluxLymphoproliferative DisordersFundoplication